Rapport Therapeutics Inc (RAPP) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Rapport Therapeutics Inc   (NASDAQ: RAPP)


Rapport Therapeutics Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Rapport Therapeutics Inc's ROI in the third quarter of 2026?
Rapport Therapeutics Inc recorded a cumulative net loss of $-150 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -33.4%.

Within the Healthcare sector 359 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 2046 to 3409.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 29.31 % 60.86 % 40.2 % 21.95 % 40.76 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 398 431 480 493 521
Return On Investment (TTM) -33.4 % -28.51 % -24.27 % -28.21 % -28.05 %
RAPP's Overall Ranking # 3409 # 2046 # 3098 # 2914 #
Seq. Investment Change TTM -6.38 % 8.88 % 11.83 % 13.44 % 16.46 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -150 -137 -107 -111 -98

RAPP Company Profile >> Back to RAPP Roi Comparisons >> See Annual RAPP Return On Investment



Return On Investment RAPP's Ranking
Within: No.
Industry # 139
Sector # 360
Overall # 3409

Return On Investment Statistics
High Average Low
-24.17 %
-26.86 %
-29.52 %
(Dec 31 2024)   (Jun 30 2025)







Financial Statements
Rapport Therapeutics Inc's III. Quarter Investments $ 398 Millions RAPP's Balance sheet
Rapport Therapeutics Inc's III. Quarter Income $ -40 Millions Quarterly RAPP's Income Statement
RAPP's Income by Division See RAPP's Income by Division


RAPP Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024


Total Investments in Millions 493 306 0 0 0
Y / Y Investment Growth 61.15 % - - - -
Net Income in Millions -111 -78 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -22.6 % -25.58 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RAPP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RAPP's Competitors
Subscribers only: Roi for Rapport Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for RAPP's Customers

Other Ratios
RAPP's Roa RAPP's Inventory Turnover Ratio RAPP's Growth Rates RAPP's Dividend Statistics
RAPP's Profitability Ratios RAPP's Asset Turnover Ratio RAPP's Dividend Growth
RAPP's Roe RAPP's Valuation Ratios RAPP's Financial Strength Ratios RAPP's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI

Date modified: 2026-11-05T10:09:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.